Business
LivaNova Appoints Lucile Blaise as Global Head of Commercialization, Obstructive Sleep Apnea
LONDON, December 02, 2025--LivaNova PLC (Nasdaq: LIVN), a market-leading medical technology company, announced Lucile Blaise has joined the Company as Global Head of Commercialization, Obstructive Sleep Apnea (OSA), effective December 1. Blaise reports to Vladimir Makatsaria, Chief Executive Officer and is a member of the Executive Leadership Team.
About this update from Resmed Inc.
[{"type":"image","alt":"","displaySize":"","headline":null,"caption":"","credit":null,"className":"","disableSlideshowImg":false,"size":{"original":{"width":4954,"height":1470,"url":"https://media.zenfs.com/en/business-wire.com/6d5852020094cad7aacc57679b69a10f"},"resized":{"url":"https://s.yimg.com/ny/api/res/1.2/Vb_ftVaB.QXyJf9jGSsrBA--/YXBwaWQ9aGlnaGxhbmRlcjt3PTk2MDtoPTI4NTtjZj13ZWJw/https://media.zenfs.com/en/business-wire.com/6d5852020094cad7aacc57679b69a10f","width":960,"height":285},"lightbox":{"url":"https://s.yimg.com/ny/api/res/1.2/V3XiVH1BF4.p8D6BGptoow--/YXBwaWQ9aGlnaGxhbmRlcjt3PTI0MDA7aD03MTI7Y2Y9d2VicA--/https://media.zenfs.com/en/business-wire.com/6d5852020094cad7aacc57679b69a10f","width":1200,"height":356}},"lazy":false},{"type":"text","content":"LONDON, December 02, 2025--(BUSINESS WIRE)--LivaNova PLC (Nasdaq: LIVN), a market-leading medical technology company, announced Lucile Blaise has joined the Company as Global Head of Commercialization, Obstructive Sleep Apnea (OSA), effective December 1. Blaise reports to Vladimir Makatsaria, Chief Executive Officer and is a member of the Executive Leadership Team.","length":367,"tagName":"p"},{"type":"text","content":""Lucile is an accomplished healthcare executive with more than 25 years of leadership in the medtech sector," Makatsaria said. "With her extensive OSA market expertise, she has a strong track record in creating new sleep therapy pathways, improving patient access to care, and building strong commercial teams. Her leadership will help us unlock transformational growth by commercializing our differentiated OSA technology. We welcome her and look forward to her contributions as we aim to transform the lives of patients with OSA."","length":552,"tagName":"p"},{"type":"text","content":"Blaise joins LivaNova after 19 years with ResMed in San Diego, a leader in the treatment of respiratory and sleep apnea conditions. She held various leadership roles in marketing, sales, and strategy, including Senior Vice President of Strategy and Business Development, President of Sleep & Respiratory Care, and Vice President Western Europe (Benelux, France, Spain, Portugal, Italy, and North Africa). Prior to ResMed, Blaise served in multiple corporate management roles in France with companies including Löwenstein Medical, Thusane, and Medtronic.","length":557,"tagName":"p"},{"type"...